Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
National Institute on Drug Abuse (NIDA) University of Texas |
---|---|
Information provided by: | National Institute on Drug Abuse (NIDA) |
ClinicalTrials.gov Identifier: | NCT00000305 |
The purpose of this study is to evaluate results of d-amphetamine - cocaine (pharmacology) interaction study.
Condition | Intervention | Phase |
---|---|---|
Cocaine-Related Disorders |
Drug: Dextroamphetamine |
Phase I |
Study Type: | Interventional |
Study Design: | Treatment |
Official Title: | Amphetamine Cocaine Interaction Study |
Ages Eligible for Study: | 18 Years to 45 Years |
Genders Eligible for Study: | Male |
Accepts Healthy Volunteers: | No |
Please contact site for information.
United States, Texas | |
University of Texas Health Science Center | |
Houston, Texas, United States, 77225 |
Principal Investigator: | John Grabowski, Ph.D. | University of Texas |
Responsible Party: | University of Texas Medical School at Houston ( F. Gerard Moeller, M.D. ) |
Study ID Numbers: | NIDA-09262-2, P50-09262-2 |
Study First Received: | September 20, 1999 |
Last Updated: | August 18, 2008 |
ClinicalTrials.gov Identifier: | NCT00000305 |
Health Authority: | United States: Federal Government |
Cocaine-Related Disorders Methamphetamine Dopamine Mental Disorders Dextroamphetamine |
Substance-Related Disorders Disorders of Environmental Origin Amphetamine Cocaine |
Dopamine Uptake Inhibitors Neurotransmitter Uptake Inhibitors Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Adrenergic Agents Sympathomimetics Adrenergic Uptake Inhibitors Physiological Effects of Drugs |
Central Nervous System Stimulants Pharmacologic Actions Autonomic Agents Therapeutic Uses Dopamine Agents Peripheral Nervous System Agents Central Nervous System Agents |